We are live on
!
Find out more
MS
Maven Securities Portfolio holdings
AUM
$5.2B
1-Year Est. Return
44.01%
This Fund
S&P 500
This Quarter
Est. Return
+28.57%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$1.01B
AUM Growth
-$202M
(-17%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-35.04%
Top 10 Holdings %
Top 10 Hldgs %
17.77%
Holding
972
New
385
Increased
62
Reduced
71
Closed
428
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AdaptHealth
AHCO
|
+$14.9M |
| 2 |
CLGX
Corelogic, Inc.
CLGX
|
+$14.2M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$13.5M |
| 4 |
GoodRx Holdings
GDRX
|
+$13.3M |
| 5 |
Sotera Health
SHC
|
+$13.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$32.8M |
| 2 |
Caesars Entertainment
CZR
|
+$22.3M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$20.7M |
| 4 |
TRIT
Triterras, Inc. Class A Ordinary Shares
TRIT
|
+$15.2M |
| 5 |
BHP
BHP
|
+$15.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.37% |
| 2 | Technology | 10.24% |
| 3 | Industrials | 10.18% |
| 4 | Financials | 8.13% |
| 5 | Consumer Discretionary | 5.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
3M
MMM
$89B
| $262K | 0.03% |
1,795
+25
| +1% | +$3.55K |
|
|
CDK
452
DELISTED
CDK Global, Inc.
CDK
| $259K | 0.03% |
+5,000
| New | +$237K |
|
453
AZZ Inc
AZZ
$4.5B
| $258K | 0.03% |
+5,445
| New | +$220K |
|
|
MCOM
454
DELISTED
micromobility.com Inc. Class A Common stock
MCOM
| $258K | 0.03% |
3
-3
| -50% | -$227K |
|
|
GOAC
455
DELISTED
GO Acquisition Corp. Class A Common Stock
GOAC
| $257K | 0.03% |
+25,156
| New | +$247K |
|
456
Cigna
CI
$76.6B
| $256K | 0.03% |
+1,230
| New | +$241K |
|
457
Texas Instruments
TXN
$255B
| $256K | 0.03% |
+1,562
| New | +$243K |
|
458
Abbott
ABT
$180B
| $255K | 0.03% |
+2,331
| New | +$253K |
|
|
SGTX
459
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $255K | 0.03% |
+409
| New | +$186K |
|
460
East-West Bancorp
EWBC
$17.9B
| $254K | 0.03% |
+5,000
| New | +$212K |
|
461
PUT
Johnson Controls International
JCI
$87.5B
| $252K | 0.02% |
+5,400
| New | +$240K |
|
462
TE Connectivity
TEL
$58.8B
| $246K | 0.02% |
+2,029
| New | +$224K |
|
463
ExxonMobil
XOM
$651B
| $246K | 0.02% |
+5,920
| New | +$222K |
|
|
SIOX
464
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $246K | 0.02% |
+86,788
| New | +$253K |
|
465
CALL
Aflac
AFL
$63.9B
| $245K | 0.02% |
+5,500
| New | +$225K |
|
466
Clarivate
CLVT
$1.3B
| $245K | 0.02% |
8,200
-21,800
| -73% | -$644K |
|
467
Regal Rexnord
RRX
$14.2B
| $243K | 0.02% |
+1,979
| New | +$219K |
|
468
Lucid Motors
LCID
$2.46B
| $242K | 0.02% |
+2,400
| New | +$235K |
|
469
Johnson & Johnson
JNJ
$635B
| $241K | 0.02% |
1,527
-1,039
| -40% | -$153K |
|
470
Dominion Energy
D
$62.5B
| $237K | 0.02% |
+3,145
| New | +$250K |
|
471
Skyworks Solutions
SWKS
$9.06B
| $237K | 0.02% |
1,549
-5,632
| -78% | -$825K |
|
|
KNTE
472
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $237K | 0.02% |
+5,952
| New | +$239K |
|
473
Humana
HUM
$46.7B
| $236K | 0.02% |
+575
| New | +$239K |
|
474
Wave Life Sciences
WVE
$1.12B
| $236K | 0.02% |
+30,000
| New | +$252K |
|
475
Elevance Health
ELV
$81.9B
| $235K | 0.02% |
+732
| New | +$225K |
|
Similar funds
AUB
AP
KACA
DDC
MIM
AAI
SDIC
SCM
Maven Securities's Q4 2020 Portfolio in Review
As of Q4 2020, Maven Securities held 972 positions worth $1.01B, down 17% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Maven Securities withdrew a net $355M in Q4 2020, closing 428 positions and reducing 71 holdings. Its most notable exit was Immunomedics Inc, an estimated $32.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, Maven Securities opened a new position in Corelogic, Inc. worth $14.7M.
- Maven Securities's largest Q4 2020 buy was Corelogic, Inc.: 189,483 shares worth $14.7M.
- Maven Securities added most to AdaptHealth in Q4 2020, an estimated $14.9M increase.
- Maven Securities's biggest Q4 2020 reduction was Triterras, Inc. Class A Ordinary Shares, cutting an estimated $15.2M.
- Maven Securities fully exited Immunomedics Inc in Q4 2020, selling an estimated $32.8M.
- Maven Securities's ten largest holdings make up 18% of its $1.01B portfolio in Q4 2020.
- Maven Securities opened 385 new positions and closed 428 in Q4 2020.
- Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.01B.
Based on Maven Securities's 13F filing for Q4 2020, filed 12 Feb 2021.